 |
Doug Macron is the editor of GenomeWeb's Gene Silencing News. He covers research and therapeutic applications of RNAi, miRNA, and other gene-silencing technologies. E-mail Doug Macron or follow his GenomeWeb Twitter account at @Genesilencing. |
Court Denies Tekmira Bids to End Alnylam Patent-Infringement Case, Disqualify Alnylam's Counsel
October 04, 2012
Court Denies Tekmira Bids to End Alnylam Patent-Infringement Case, Disqualify Alnylam's Counsel
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Alnylam, Isis Sue Tekmira for Patent Infringement as Legal Saga Continues
January 19, 2012 / Gene Silencing News - Canadian Court Issues Injunction Ordering AlCana to Return Tekmira Documents, Information
January 12, 2012 / Gene Silencing News - Alnylam, Tekmira End Litigation with $65M Settlement
November 15, 2012 / Gene Silencing News - Alnylam Says Estimates of Damages in Tekmira Suit Could Reach $1.5B
November 8, 2012 / Gene Silencing News - Tekmira Official Sees 'Resolution' to Alnylam Dispute Before Year End
May 17, 2012 / Gene Silencing News